Dequalinium-based bitopic ligands uncover distinct pharmacological modulation of muscarinic receptors
Biochemical Pharmacology · 2026
DOI: 10.1016/j.bcp.2026.118019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Rebecca Ferrisi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Milan, Section of Medicinal Chemistry "Pietro Pratesi", Via L. Mangiagalli 25, 20133 Milano, Ita…. Hauptthemen laut MEDLINE: Receptors, Muscarinic, Muscarinic Agonists, Muscarinic Antagonists. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Milan.
Abstract (Originalsprache)
Bitopic ligands represent a powerful strategy to modulate G protein-coupled receptors by simultaneously engaging orthosteric and allosteric binding sites. In this study, we designed and synthesized two series of dequalinium-based hybrid ligands targeting muscarinic acetylcholine receptors (mAChRs), in which a dequalinium fragment was linked through polymethylene spacers of variable length either to the orthosteric superagonist iperoxo (Deq-X-Iper, 5a-c) or to a molecular portion of the allosteric inverse agonist W84 (Deq-X-W84, 6a-c). Equilibrium and kinetic binding studies at human mAChR subtypes (hM1-hM5) revealed good to high affinity for all compounds and a consistent bitopic mode of action, supported by a spacer-length-dependent enhancement of both orthosteric and allosteric interactions. Functional assays showed that Deq-X-W84 derivatives act as unselective muscarinic antagonists, whereas Deq-X-Iper ligands behave as agonists. Notably, the latter displayed probe-dependent negative allosteric modulation of acetylcholine-induced ERK1/2 phosphorylation at the hM4 receptor, revealing an unexpected functional profile. Docking and molecular dynamics simulations provided a structural rationale for these findings, highlighting stable bitopic binding poses and linker-dependent optimization of receptor contacts. Overall, these results demonstrate that dequalinium-based bitopic ligands can encode distinct functional outcomes at muscarinic receptors, offering new insights into the design of ligands with tailored signaling profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Milan, Section of Medicinal Chemistry "Pietro Pratesi", Via L. Mangiagalli 25, 20133 Milano, Italy.
- Department of Neuroscience, Psychology, Drug Research and Child's Health, Section of Pharmacology and Toxicology, University of Florence, Viale G. Pieraccini 6, 50139 Firenze, Italy.
- Department of Food and Drug, University of Parma, Viale Delle Scienze, 27/A, 43124 Parma, Italy.
- Department of Pharmaceutical Sciences, University of Milan, Section of Medicinal Chemistry "Pietro Pratesi", Via L. Mangiagalli 25, 20133 Milano, Italy. Electronic address: clelia.dallanoce@unimi.it.
Förderung
- University of Milan
Zitieren
APA
Ferrisi, R., Vittorio, S., Morando, S., Giorgio, C., Brivio, N., Cortese, E., Colleoni, A., Papotto, C., Matera, C., Amici, M., Barocelli, E., Vistoli, G., Matucci, R., & Dallanoce, C. (2026). Dequalinium-based bitopic ligands uncover distinct pharmacological modulation of muscarinic receptors. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118019
Vancouver
Ferrisi R, Vittorio S, Morando S, Giorgio C, Brivio N, Cortese E, et al. Dequalinium-based bitopic ligands uncover distinct pharmacological modulation of muscarinic receptors. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.118019
BibTeX
@article{Ferrisi2026,
author = {Ferrisi, Rebecca and Vittorio, Serena and Morando, Simone and Giorgio, Carmine and Brivio, Nicolò and Cortese, Elisabetta and Colleoni, Alessio and Papotto, Claudio and Matera, Carlo and Amici, Marco De and Barocelli, Elisabetta and Vistoli, Giulio and Matucci, Rosanna and Dallanoce, Clelia},
title = {Dequalinium-based bitopic ligands uncover distinct pharmacological modulation of muscarinic receptors},
journal = {Biochemical Pharmacology},
year = {2026},
doi = {10.1016/j.bcp.2026.118019}
}
EUVIMED